Download PDF
Exp Clin Endocrinol Diabetes 2007; 115(10): 694-696
DOI: 10.1055/s-2007-985361
Short Communication

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Unusual Adrenal Metastasis and Abdominal Carcinomatosis Secondary to Hurthle Cell Carcinoma of the Thyroid

S. Namwongprom 1 , 2 , R. F. Núñez 1 , H. W. Yeung 1 , E. E. Kim 1 , H. A. Macapinlac 1
  • 1The Department of Nuclear Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • 2Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
Further Information

Publication History

received 03.06.2007 first decision 13.07.2007

accepted 13.07.2007

Publication Date:
30 November 2007 (online)

Also available at
    Permissions and Reprints

Abstract

Hurthle cell carcinoma (HCC) of the thyroid is an uncommon and relatively rare differentiated thyroid neoplasm. To our knowledge, no reported case of adrenal metastases with abdominal carcinomatosis secondary to HCC of the thyroid has been demonstrated by F-18 FDG PET/CT imaging. One report of adrenal uptake on I-131 whole-body scan with HCC exists. In this case report, we describe a patient with HCC who had a left adrenal metastasis with abdominal carcinomatosis that was discovered using F-18 FDG PET/CT imaging.

Key words

adrenal metastasis - abdominal carcinomatosis - Hurthle cell carcinoma - PET/CT imaging

References

  • 1 Azadian A, Rosen IB, Walfish PG, Asa SL. Management considerations in Hurthle cell carcinoma.  Surgery. 1995;  118 711-714
    PubMedGoogle Scholar
  • 2 Orsolon P, Bagni B, Geatti O, Guerra UP. An unusual adrenal metastasis secondary to Hurthle cell carcinoma of the thyroid.  Clinical Nuclear Medicine. 1996;  21 312-315
    CrossrefPubMedGoogle Scholar
  • 3 Cooper DS, Schneyer CR. Follicular and Hurthle cell carcinoma of the thyroid.  Endocrinology and metabolism clinics of North America. 1990;  19 577-591
    PubMedGoogle Scholar
  • 4 Hamann A, Gratz KF, Soudah B, Fritsch RS, Georgii A, Hundeshagen H. The clinical course of oxyphilic carcinoma of the thyroid.  Nuklearmedizin. 1992;  31 230-238
    PubMedGoogle Scholar
  • 5 Har-El G, Hadar T, Segal K, Levy R, Sidi J. Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy.  Cancer. 1986;  57 1613-1617
    CrossrefPubMedGoogle Scholar
  • 6 Tollefsen HR, Shah JP, Huvos AG. Hurthle cell carcinoma of the thyroid.  American Journal of Surgery. 1975;  130 390-394
    CrossrefPubMedGoogle Scholar
  • 7 Watson RG, Brennan MD, Goellner JR, Heerden JA, MacConahey WM, Taylor WF. Invasive Hurthle cell carcinoma of the thyroid: natural history and management.  Mayo Clinic proceedings. 1984;  59 851-855
    PubMedGoogle Scholar
  • 8 Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J. Follicular Hurthle cell tumors of the thyroid.  Cancer. 1991;  68 1944-1953
    CrossrefPubMedGoogle Scholar
  • 9 Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid.  American Journal of Surgery. 1996;  172 692-694
    CrossrefPubMedGoogle Scholar
  • 10 Lowe VJ, Mullan BP, Hay ID, Maclver B, Kasperbuer JL. 18F-FDG PET of patients with Hurthel cell carcinoma.  Journal of Nuclear Medicine. 2003;  44 1402-1406
    PubMedGoogle Scholar
  • 11 Pryma DA, Schoder H, Gonen M, Robbins RJ, Larson SM, Yeung HW. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hurthle cell thyroid cancer patients.  Journal of Nuclear Medicine. 2006;  47 1260-1266
    PubMedGoogle Scholar
  • 12 Sugino K, Ito K, Mimura T, Kameyama K, Iwasaki H, Ito K. Hurthle cell tumor of the thyroid: analysis of 188 cases.  World Journal of Surgery. 2001;  25 1160
    PubMedGoogle Scholar
  • 13 Kushchayeva Y, Duh QY, Kebebew E, Clark OH. Prognostic indica-tions for Hurthle cell cancer.  World Journal of Surgery. 2004;  28 1266-1270
    CrossrefPubMedGoogle Scholar
  • 14 Yutan E, Clark OH. Hurthle cell carcinoma.  Current treatment options in oncology. 2001;  2 331-335
    CrossrefPubMedGoogle Scholar
  • 15 Chen H, Nicol TL, Zeiger MA, Dooley WC, Ladenson PW, Cooper DS, Ringel M, Parkerson S, Allo M, Udelsman R. Hurthle cell neoplasms of the thyroid: are there factors predictive of malignancy.  Annals of Surgery. 1998;  227 542-546
    CrossrefPubMedGoogle Scholar

Correspondence

S. NamwongpromMD 

Department of Nuclear Medicine

Unit 1264

The University of Texas M. D. Anderson Cancer Center

1515 Holcombe Blvd.

Houston

77030 Texas

Phone: +1/713/792 70 31

Fax: +1/713/563 36 93

Email: snamwong@mail.med.cmu.ac.th

      >